“Medication for addiction treatment with buprenorphine or methadone is an appropriate and accepted treatment for pregnant women with opioid use disorder (OUD), according to new research.
The report, prepared by University of North Carolina’s Hendree E. Jones and colleagues, is an important step toward developing evidence-based recommendations for treatment of pregnant and parenting women with OUD and their children.
Jones and coauthors wrote: “Practical recommendations will help providers treat pregnant women with OUD and reduce potentially negative health consequences for mother, fetus, and child.”
The study appears in the Journal of Addiction Medicine.
The SiaSat Daily – April 16, 2017